SBH
MIRM icon

Segall Bryant & Hamill’s Mirum Pharmaceuticals MIRM Stock Holding History

Segall Bryant & Hamill’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21M Buy
178,980
+3,082
+2% +$309K 0.25% 150
2026
Q1 		$16.2M Sell
175,898
-9,126
-5% -$859K 0.23% 162
2025
Q4 		$14.6M Buy
+185,024
New +$13.3M 0.2% 181

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Segall Bryant & Hamill's MIRM Position: Q2 2026 in Review

Segall Bryant & Hamill increased its Mirum Pharmaceuticals (MIRM) stake by 1.8% in Q2 2026, buying an estimated $309K and bringing the position to 178,980 shares worth $21M. The position accounts for 0.25% of the portfolio, ranked #150.

Segall Bryant & Hamill first reported a position in MIRM in Q4 2025 and has held it in 3 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Segall Bryant & Hamill held 178,980 shares of Mirum Pharmaceuticals worth $21M as of Q2 2026.
  • Segall Bryant & Hamill bought 3,082 Mirum Pharmaceuticals shares in Q2 2026, an estimated $309K.
  • Mirum Pharmaceuticals made up 0.25% of Segall Bryant & Hamill's portfolio in Q2 2026, its #150 holding.
  • Segall Bryant & Hamill first reported a position in Mirum Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Segall Bryant & Hamill's 13F filing for Q2 2026, filed 12 Aug 2026.